Obama-Proof: Pfizer, Bristol-Myers and Teva

TSC Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its "safety first" approach to investing aims to reduce risk while seeking solid outperformance on a total return basis.

When President Barack Obama proposed offering health care coverage to all Americans, the industry bristled and investors cringed.

But some drugmakers will gain even if the president's plan erodes profits by lowering prices. Pfizer(PFE Quote), Bristol-Myers Squibb(BMY Quote) and Teva Pharmaceuticals(TEVA Quote) are three of them. Recommended as "buy" by TheStreet.com Ratings, the companies offer products and possess sound businesses that investors can be confident in. ...